Fu-Shun YenJames Cheng-Chung WeiYu-Han HuangPei-Yun LiFuu-Jen TsaiChih-Cheng HsuChii-Min Hwu2026-02-052026-02-052025-0810.1016/j.diabres.2025.112328https://scholars.csmu.edu.tw/handle/123456789/5268[SDGs]SDG3Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetesjournal-article